| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/12/2012 | WO2012004245A1 Crystalline form of rivaroxaban dihydrate |
| 01/12/2012 | WO2012004234A1 Sn-2-monoacylglycerols and lipid malabsorption |
| 01/12/2012 | WO2012004228A1 Use of glabranin for stimulating hair growth |
| 01/12/2012 | WO2012004227A1 Malvidin for promoting hair growth |
| 01/12/2012 | WO2012004217A1 Cyclic ether compounds useful as kinase inhibitors |
| 01/12/2012 | WO2012004212A1 Heterocyclic antiviral compounds |
| 01/12/2012 | WO2012004207A1 (3 -methylpyrrolidin- 3 - yl) methyl pyridinyl ether derivatives and their use as nk-3 receptor antagonists |
| 01/12/2012 | WO2012004206A1 Anellated pyridine compounds |
| 01/12/2012 | WO2012004063A1 Biotechnological production of chondroitin |
| 01/12/2012 | WO2012003987A1 Oral dosage form of deferasirox |
| 01/12/2012 | WO2012003968A1 Novel gastro- retentive dosage forms comprising a gaba analog and an opioid |
| 01/12/2012 | WO2012003960A1 Topical application of erythropoietin for the treatment of eye disorders and injuries |
| 01/12/2012 | WO2012003912A1 Bipyridyl derivatives useful for the treatment of kinase - induced diseases |
| 01/12/2012 | WO2012003829A1 Novel homopiperazine derivatives as protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 01/12/2012 | WO2012003811A1 C-aryl glucoside sglt2 inhibitors and method |
| 01/12/2012 | WO2012003804A1 Pharmaceutical composition of silybin and preparation method thereof |
| 01/12/2012 | WO2012003802A1 Use of 5α-androstane (alkyl)-3β,5,6β-triol in preparing neuroprotective drugs |
| 01/12/2012 | WO2012003784A1 Pyrazine derivatives,process for manufacture and use thereof |
| 01/12/2012 | WO2012003704A1 Sodium alginate crosslinked slow-released moxiflorxacin microsphere, the preparation method and the use thereof, and target vascular occlusive agent of the microsphere |
| 01/12/2012 | WO2012003642A1 Fused tricyclic compounds and use thereof for treating viral diseases |
| 01/12/2012 | WO2012003576A1 Imidazopyridine, imidazopyrimidine and imidazopyrazine derivatives as melanocortin-4 receptor modulators |
| 01/12/2012 | WO2012003563A1 Antineoplastic pharmaceutical compositions containing substituted nitroaromatic compounds |
| 01/12/2012 | WO2012003562A1 Antineoplastic pharmaceutical compositions containing substituted nitroimidazoles |
| 01/12/2012 | WO2012003554A2 Compositions and methods for removal or destruction of amyloid fibril or amyloid adhesin comprising aggregates |
| 01/12/2012 | WO2012003545A1 Acetylenation of fatty acids |
| 01/12/2012 | WO2012003544A1 Protein kinase inhibitors and methods of treatment |
| 01/12/2012 | WO2011148253A3 Solid dosage forms of antipsychotics |
| 01/12/2012 | WO2011146821A3 1 - phenylmorpholine derivatives as hydroxybupropion analogues for treating drug dependence |
| 01/12/2012 | WO2011139420A3 Propynylaminoindan transdermal compositions |
| 01/12/2012 | WO2011129427A9 Diagnostic agent and therapeutic agent for cancer |
| 01/12/2012 | WO2011123678A3 Substituted benzo-pyrido-triazolo-diazepine compounds |
| 01/12/2012 | WO2011119929A3 Composition for enhancing athletic performance |
| 01/12/2012 | WO2011119585A3 Aerosol foams comprising clindamycin phosphate |
| 01/12/2012 | WO2011117322A3 Use of caffeine and aspirin in synergistic amounts for improving performance |
| 01/12/2012 | WO2011116356A3 Positive allosteric modulators of group ii mglurs |
| 01/12/2012 | WO2011116020A3 Ophthalmic formulations of cetirizine and methods of use |
| 01/12/2012 | WO2011115778A9 Aerosolized dapsone as a therapy for inflammation of the airway and abnormal mucociliary transport |
| 01/12/2012 | WO2011113060A3 Antiviral compounds and methods of use thereof |
| 01/12/2012 | WO2011112900A3 Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof |
| 01/12/2012 | WO2011112731A3 Heterocyclic inhibitors of histamine receptors for the treatment of disease |
| 01/12/2012 | WO2011111971A3 Method for preparing (r)-3-(3-fluoro-4-(1-methyl-5,6-dihydro-1,2,4-triazin-4(1h)-yl)phenyl)-5-(substituted methyl)oxazolidin-2-one derivatives |
| 01/12/2012 | WO2011110546A3 Pharmaceutical composition comprising an inhibitor of shp-2 and screening method |
| 01/12/2012 | WO2011109411A9 Sandalwood oil and its uses |
| 01/12/2012 | WO2011108882A3 Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient |
| 01/12/2012 | WO2011107867A3 Compound and composition and their use in the treatment of diseases related to copper retention |
| 01/12/2012 | WO2011106577A3 Method for treating brain cancer |
| 01/12/2012 | WO2011106574A9 Inhibitors for antiviral use |
| 01/12/2012 | WO2011106525A9 Methods of treating cerebral amyloid angiopathy |
| 01/12/2012 | WO2011105825A3 Resveratrol effective in treating and preventing prion diseases |
| 01/12/2012 | WO2011103413A3 Taxane pro-emulsion formulations and methods making and using the same |
| 01/12/2012 | WO2011103202A3 Androgen receptor modulators and uses thereof |
| 01/12/2012 | WO2011102657A3 Composition for percutaneous administration of tolterodine with improved skin permeation |
| 01/12/2012 | WO2011100685A3 Methods of generating hyper inos expressing cells and uses thereof |
| 01/12/2012 | WO2011099832A3 Novel benzimidazole compound, preparation method thereof and pharmaceutical composition comprising the same |
| 01/12/2012 | WO2011094708A3 Small molecules for the modulation of mcl-1 and methods of modulatiing cell death, cell division, cell differentiation and methods of treating disorders |
| 01/12/2012 | WO2011087765A3 Methods of producing stabilized solid pharmaceutical compositions containing morphinans |
| 01/12/2012 | WO2011068934A4 Vaccine against neoplastic or cancerous lesions caused by human papillomavirus (hpv), procedures, uses and methods |
| 01/12/2012 | WO2011068872A3 Carboxyvinyl polymer-containing nanoparticle suspension |
| 01/12/2012 | WO2011058336A3 Tablet comprising gum arabic |
| 01/12/2012 | WO2011048613A3 Emergency contraceptive |
| 01/12/2012 | WO2011047173A3 Pharmaceutical compositions for oral administration |
| 01/12/2012 | WO2010135524A8 Benzoxazepines based p13k/mt0r inhibitors against proliferative diseases |
| 01/12/2012 | WO2010134048A3 Topical retinoid solutions |
| 01/12/2012 | WO2010072958A3 Topical pharmaceutical composition containing a water-sensitive active principle |
| 01/12/2012 | WO2010017152A3 Modulation of toll-like receptor 8 expression by antisense oligonucleotides |
| 01/12/2012 | US20120010599 Inorganically surface-modified polymers and methods for making and using them |
| 01/12/2012 | US20120010557 Drug Delivery System for Use in the Treatment of Vascular and Vessel-Related Pathologies |
| 01/12/2012 | US20120010299 Non-prescription medicine, vital fluid, and/or nutritional supplement |
| 01/12/2012 | US20120010298 Method for synthesizing (E)-Anethol and Related Compounds By Cross Coupling Reaction of Potassium alllyltrifluroborate and 4-bromoanisole and aryl halides |
| 01/12/2012 | US20120010297 Curcuminoids and its metabolites for the application in allergic ocular/nasal conditions |
| 01/12/2012 | US20120010296 Treating various disorders with catechol-o-methyl-transferase inhibitors |
| 01/12/2012 | US20120010295 Synergistic combinations comprising a renin inhibitor for cardiovascular diseases |
| 01/12/2012 | US20120010294 Compositions and methods for the inhibition of muscle contraction |
| 01/12/2012 | US20120010293 Droxidopa and pharmaceutical composition thereof for the treatment of mood disorders, sleep disorders, or attention deficit disorders |
| 01/12/2012 | US20120010292 Modification i of 4-(phenyl)ethyl]-amino}methyl)benzoic acid |
| 01/12/2012 | US20120010291 CREATINE Beta-ALANINATE: A NOVEL SALT FOR INCREASING ATHLETIC PERFORMANCE |
| 01/12/2012 | US20120010290 Methods of Treating an Overweight or Obese Subject |
| 01/12/2012 | US20120010289 Method for placental exfoliation using oxo-arachidonic acid or the like |
| 01/12/2012 | US20120010288 Method for protecting a retinal neuronal cell |
| 01/12/2012 | US20120010287 N, n -dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
| 01/12/2012 | US20120010286 Prevention of neutrophil recruitment |
| 01/12/2012 | US20120010285 Agent for promoting energy consumption |
| 01/12/2012 | US20120010284 Controlled release of biologically active compounds from multi-armed oligomers |
| 01/12/2012 | US20120010283 Modulation of anxiety through blockade of anandamide hydrolysis |
| 01/12/2012 | US20120010282 Tautomycetin and Tautomycetin Analog Biosynthesis |
| 01/12/2012 | US20120010281 Antimicrobial and antitubercular compounds |
| 01/12/2012 | US20120010280 Ophthalmic compositions based on polyunsaturated omega-3 and omega-6 fatty acids |
| 01/12/2012 | US20120010279 Composition comprising (-)-delta9-trans-tetrahydrocannabinol |
| 01/12/2012 | US20120010278 Use of Artemisinin for Treating Tumors Induced by Oncogenic Viruses and for Treating Viral Infections |
| 01/12/2012 | US20120010277 Avermectin compounds and treatment of dermatological disorders in humans therewith |
| 01/12/2012 | US20120010276 Screening and therapy for lymphatic disorders involving the flt4 receptor tyrosine kinase (vegfr-3) |
| 01/12/2012 | US20120010274 Genetic polymorphisms associated with psoriasis, methods of detection and uses thereof |
| 01/12/2012 | US20120010273 Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor |
| 01/12/2012 | US20120010272 RNA Interference Mediated Inhibition of Apoptosis Signal-Regulating Kinase 1 (ASK1) Gene Expression Using Short Interfering Nucleic Acid (siNA) |
| 01/12/2012 | US20120010271 Single-stranded nucleic acid molecule for controlling gene expression |
| 01/12/2012 | US20120010270 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN TUMOR SUPPRESSING SUBTRANSFERABLE CANDIDATE 6 (TSSC6) |
| 01/12/2012 | US20120010269 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN SMS3 |
| 01/12/2012 | US20120010268 ISOLATED GENOMIC POLYNUCLEOTIDE FRAGMENTS FROM THE p15 REGION OF CHROMOSOME 11 ENCODING HUMAN ACHAETE-SCUTE HOMOLOG 2 (HASH2) |
| 01/12/2012 | US20120010267 RNAi MODULATION OF MLL-AF4 AND USES THEREOF |
| 01/12/2012 | US20120010266 Tbc1d7 as tumor marker and therapeutic target for cancer |